BMO Capital Markets adjusted its price target for FactSet Research Systems (NYSE:FDS) shares, lowering it to $498.00 from the previous $518.00, but retained a Market Perform rating on the stock.

Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...